HLS vs MVP

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

HLS

HEALIUS FPO [HLS]

54MEDIUM

MVP

MEDICALDEV FPO [MVP]

57MEDIUM

Score Breakdown

HLS MVP
Technical
68
37
Catalyst
87
54
Sentiment
50
50
Fundamental
90
95
Momentum
34
49
Risk Gate
32
50

Key Metrics

HLS Metric MVP
$275.9MMarket Cap$45.6M
4.3MAvg Volume (20d)136K
+10.1%Short InterestN/A
$1.07052-Week High$0.765
$0.30052-Week Low$0.365
+3.2%Daily Change+0.0%
$0.392Reference Price$0.405
-69.3%ROE-0.8%
-12.3%Profit Margin-1.1%

Active Signals

HLS Signals

●MACD momentum is picking up steam
●Bollinger Bands are tightening — volatility is coiling up for a potential breakout
●Trading above both moving averages — the trend is your friend here
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (0.2x)
●EPS estimates revised upward (+10pts)
●Near 52-week low (10% of range)

MVP Signals

●MACD crossed bearish — momentum is fading
●Drifting lower — down 6.9% over the last 5 days
●Beating the Small Ords index — relative strength of 1.15, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●4C filed 2026-04-23
●Low P/S ratio (1.1x)
●Moderate revenue growth (+8%)

Ask Scout AI to compare HLS and MVP in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

HLS vs MYX →HLS vs NOX →HLS vs NUZ →HLS vs NXN →HLS vs PAR →
HLS Full Analysis → MVP Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).